HEALTH CARE UTILIZATION (HCU) BY BREAST CANCER (BC) AND NON-HODGKIN LYMPHOMA (NHL) PATIENTS WITH CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA (FN) IN THE NETHERLANDS

被引：0
|
作者：
Issa, D. E. [1 ]
van Herk-Sukel, M. P. P. [2 ]
Gelderblom, H. [3 ]
Houweling, L. M. A. [2 ]
Jager, A. [4 ]
De La Orden, M. [5 ]
Lugtenburg, P. J. [4 ]
van der Werf-Langenberg, M. E. [6 ]
Nortier, J. W. R. [3 ]
de Jong, F. A. [6 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] PHARMO Inst, Utrecht, Netherlands
[3] Leiden Univ Med Ctr, Leiden, Netherlands
[4] Erasmus MC, Rotterdam, Netherlands
[5] Amgen Inc, Uxbridge, Middx, England
[6] Amgen BV, Breda, Netherlands
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A435 / A435
页数：1
相关论文
共 50 条
  • [21] Chemotherapy-induced febrile neutropenia (FN) and FN prevention strategies in cancer care in the US Veterans Health Administration (VHA)
    Barron, Richard L.
    Wang, Li
    Baser, Onur
    Langeberg, Wendy J.
    Dale, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Breast cancer (BC) after curative chemotherapy (CT) in non-hodgkin's lymphoma (NHL): Drug resistance as the major cause of treatment failure
    Tsavaris, N
    Zorzos, C
    Kosmas, C
    Lazaris, A
    Katsorida, M
    Pangalis, G
    Davaris, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S196 - S196
  • [23] Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice
    Weycker, Derek
    Danel, Aurelie
    Marciniak, Anne
    Bendall, Kate
    Lipsitz, Michael
    Pettengell, Ruth
    BMC CANCER, 2012, 12
  • [24] Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin’s lymphoma in European and Australian clinical practice
    Derek Weycker
    Aurelie Danel
    Anne Marciniak
    Kate Bendall
    Michael Lipsitz
    Ruth Pettengell
    BMC Cancer, 12
  • [25] Prophylactic pegfilgrastim is safe and effective for chemotherapy-induced neutropenia in patients with Hodgkin disease and non-Hodgkin lymphoma
    Gregory, S
    Grigg, A
    Moore, T
    PROCEEDINGS OF THE XVII MEETING INTERNATIONAL SOCIETY OF HAEMATOLOGY (EUROPEAN AND AFRICAN DIVISION), 2003, : 231 - 237
  • [26] Intra-hospital survival of non-Hodgkin's lymphoma patients with febrile neutropenia
    Ouyang, Lamei
    Wang, Daofeng
    Fang, Yi
    Liu, Xiao
    Li, Huan
    Lou, Ning
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (05): : 8648 - 8655
  • [27] External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma
    Schwenkglenks, Matthias
    Bendall, Kate Louise
    Pfeil, Alena M.
    Szabo, Zsolt
    Pettengell, Ruth
    LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2426 - 2432
  • [28] Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN study
    Ishikawa, Takashi
    Sakamaki, Kentaro
    Narui, Kazutaka
    Kaise, Hiroshi
    Tsugawa, Koichiro
    Ichikawa, Yasushi
    Mukai, Hirofumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (07) : 692 - 695
  • [29] Prospective cohort study of febrile neutropenia in breast cancer patients with neoadjuvant and adjuvant chemotherapy: CSPOR-BC FN Study
    Ishikawa, Takashi
    Sakamaki, Kentaro
    Narui, Kazutaka
    Nishimura, Hideki
    Sangai, Takafumi
    Tamaki, Kentaro
    Hasegawa, Yoshie
    Watanabe, Ken-ichi
    Suganuma, Nobuyasu
    Michishita, Shintaro
    Sugae, Sadatoshi
    Aiharya, Tomohiko
    Tsugawa, Koichiro
    Kaise, Hiroshi
    Mukai, Hirofumi
    CANCER RESEARCH, 2020, 80 (04)
  • [30] Management of Breast Cancer Patients with Chemotherapy-Induced Neutropenia or Febrile Neutropenia
    Fontanella, Caterina
    Bolzonello, Silvia
    Lederer, Bianca
    Aprile, Giuseppe
    BREAST CARE, 2014, 9 (04) : 239 - 245
12345